Tender Detail with Corrigendum

Corrigendum - 7 Published On : 20/12/2019
Corrigendum Details :Second Extension
Corrigendum Type :Date
Corrigendum Document : Available Corrigendum Document For Download
Corrigendum - 6 Published On : 14/12/2019
Corrigendum Details :First Extension
Corrigendum Type :Date
Corrigendum Document : Available Corrigendum Document For Download
Corrigendum - 5 Published On : 02/12/2019
Corrigendum Details :corrigendum 4
Corrigendum Type :Date
Corrigendum Document : Available Corrigendum Document For Download
Corrigendum - 4 Published On : 27/11/2019
Corrigendum Details :Corrigendum
Corrigendum Type :Date
Corrigendum Document : Available Corrigendum Document For Download
Corrigendum - 3 Published On : 22/11/2019
Corrigendum Details :Corrigendum II
Corrigendum Type :Date
Corrigendum Document : Available Corrigendum Document For Download
Corrigendum - 2 Published On : 13/11/2019
Corrigendum Details :Corrigendum 1
Corrigendum Type :Date
Corrigendum - 1 Published On : 13/11/2019
Corrigendum Details :Corrigendum 1
Corrigendum Type :Date
Corrigendum Document : Available Corrigendum Document For Download
Buyer/Seller : Can be viewed by Subscribers
Ref. Number : 37139168 Tender Number : 2019_HBPCL_503001_1 Tender Prod. No : 2019_HBPCL_503001_1
Requirement : Supply of injections phase - "injection ticarcillin [tic tac toe car pen] injection ticarcillin disodium 3 gm + clavulanate potassium 100 mg, ", tigecycline 50 mg injection, tirofiban 50mcg/ml injection, tramadol 50 mg/ml injection, tramadol 50 mg /ml injection, tranxamic acid 500 mg/ 5 ml, urokinase 5 lac i.u. injection , urokinase 10,00,000 iu injection. , ulinastatin 100000 iu injection, valathamide bromide 8 mg/ml injection, vancomycin hcl 500 mg injection, vancomycin 1 gm injection. , vecuronium bromide 4 mg injection, vecuronium bromide 10 mg per ampoule of 10 ml injection. , vitamin b. complex injection, vitamin b1 100 mg + b6 100 mg + b12 1000 mcg injection, vitamin k injection. (menadione) 10 mg/ml injection, "injectionection of calcium with vit b12 & d3 each ml contains , calcium lavulinate ip 75mg, cynocobalamine ip 100mcg, vitamin d3 ip 10000iu, lignocaine hci ip 10mg, phenol ip 0.5% w/v, (as preservative), water for injectionection ip q.s.", "injectionection of calcium with vit b12 & d3 each ml contains , calcium lavulinate ip 75mg, cynocobalamine ip 100mcg, vitamin d3 ip 10000iu, lignocaine hci ip 10mg, phenol ip 0.5% w/v, (as preservative), water for injectionection ip q.s.", dexmedetomidine 100mcg/ml injection, dexmedetomidine 100mcg /ml injection, non ionic 370 iopromide / ioversol / iohexol / iopamidol 370 mg/ml, non-ionic 370 iopromide / ioversol /iohexol / iopamidol 370 mg/ml, non-ionic 350 iopromide / ioversol / iohexol / iopamidol 350 mg/ml, non -ionic 350 iopromide / ioversol /iohexol / iopamidol 350 mg/ml, non- ionic 300 iopromide/ioversol/ iohexol / iopamidol 300 mg/ml, non- ionic 300 iopromide/ioversol/ iohexol / iopamidol 300 mg/ml, oral contrast sodium diatrizoate meglumine diatrizoate (iodine content 370 mg/ml) 370 mg/ml, mri contrast media injection. gadolinium / gadoversetamide / gadodiamide / gadopentetate 0.5 molar 0.5 mmol / ml, rabies vaccines, human (cell culture) potency of not less than 2.5 units per vial. i.p. for id use (tissue culture anti rabies vaccines) injection, rabies vaccines, human (cell culture) potency of not less than 2.5 units per vial. i.p. for im use (tissue culture anti rabies vaccines) injection, premix insulin 3070 injectionection recombinant human insulin biphasic 30%, regular 70% 100 iu/ml , injection. hyluronidase 2ml, injection. adrenaline 1 ml, injection dulaglutide 1.5mg/vial, insulin (soluble) injectionection 40 iu/ml, injection. human albumin 5% (isotonic), 250 ml , linezolid injection. 100 mg/ml 100 ml, oxytocin injection 10 iu 1 ml 2 ampule, injection. paliperidone palmitate 100mg, phytomenadione (vitamin k1), promethazine injection 50mg/ml , injection. tenecteplase 40mg, injection. vitamin k with disposable syringe starile with needle 1 inch 2 ml, reteplase rpa = recombinant human tissue pasminogen activator, injection. hydroxyethyl starch (hetastarch) 6% 500, hepatitis- b immunoglobulin 100 iu , hepatitis- b immunoglobulin 200 iu , injection. quinine & artesunate, injection.premixed human insulin analogue injection (biosynthetic r-dna origin) mixture of soluble inslin aspart 30% and protamine crystallised insunil aspart 70% 100 iu / ml in 3.0 ml cartridges., injection. insulin degludec (r-dna origin) solution for subcutaneous injectionection. 1 ml solution contains 100 units of insulin degludec (equivalent to 3.66 mg ), each pre-filled pen contains 300 units of insulin degludec in 3 ml solution., caffine citreate 20mg/ml 3ml p , drotaverine hcl 20mg /ml , injection lacosamide 10 mg / ml, injection colistimethate sodium for injectionection i p 1 miu, vitamin k injection.1 mg/ml injection (phytonadione), injection triamcinolone acetonide 10 mg, injection triamcinolone acetonide 40 mg, injection lung surfactant , injection lung surfactant , injection phosphenytoin 2 ml, rabies immunoglobulin 150iu/ml, flavoured ionic water soluble oral contrast agent for gi tract, injection . meglumine diatrizoate sodium diatrizoate iodine content 365 -375 mg /ml. in 20 ml ampule / vial , injection non ionic contrast for intravascular use iodine concentration 300 mg /ml 100 ml vial , injection non ionic contrast for intravascular use iodine concentration 350-370 mg /ml 100 ml vial or scan bags packing may be accepted subject to provision of injectionector at free of cost , injection non ionic contrast for intravascular use iodine concentration 400 mg/ml ( 100 ml bottle ) , micro bubble best ultrasound contrast media for radiology /cardiology ( 2d echo ) ( liquid / powder for constituting 5 ml volume ), injection. gadolinium base contrast for m.r.i for pediatrics use , injection .gadolinium base contrast for m.r.i use liver /liver specific ( should have hepatobiliary excretion , injection . gadolinium best contrast for m.r.i for general use , injection. gadolinium base contrast for m.r.i use angiography, formulated flavoured neutral oral contrast manitol based [100ml], injection. l-ornithine asparate , injection. clonidine hcl 150mcg/ml 1ml, injection.human rabies immunoglobuline 2ml 300iu, human hepatitis immunoglobulin 100i.u. /ml , influenza vaccine 0.5ml, ropivacaine 0.75%20 ml, terlipressin 1 mg/ 10 ml amp, ceftriaxone sodium 1 gm + sulbactam 500 mg, vac. typhoid single dose , balanced salt solution (glass bottle) injection

Key Values

Document Fees : 433,200
EMD : 4,560,000
Tender Estimated Cost : 934,125,421
Closing Date : 26/12/2019
Document Sale To : 13/11/2019
Location : Maharashtra - India

Value Added Services

  • Get consortium partner
  • Get Winning Estimate
  • Track Tender Result
  • Get Subcontractors
  • Find Liaison Agency
  • Ask Expert

Disclaimer : Tender Tiger takes all possible care to ensure accurate & authentic tender information however it cannot be held responsible for Omissions, Errors, etc. Users are advised to refer to Tender Document published by Procuring entity before they take submit their actual bid.